
ATNXQ
Healthcare · Drug Manufacturers - Specialty & Generic
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Jun 30, 2023 | Before the open | -1.71 | 0.00 | +100.0% |
| Mar 14, 2023 | Time not confirmed | -1.73 | -3.22 | -86.1% |
| Nov 3, 2022 | Time not confirmed | -0.15 | -0.14 | +6.7% |
| Jul 28, 2022 | Time not confirmed | -0.15 | -0.28 | -86.7% |
| May 10, 2022 | Time not confirmed | -0.19 | -0.16 | +15.8% |
| Mar 16, 2022 | Time not confirmed | -0.33 | -0.95 | -191.4% |
| Nov 4, 2021 | Time not confirmed | -0.36 | -0.33 | +7.9% |
| Aug 5, 2021 | Time not confirmed | -0.37 | -0.33 | +10.0% |
| May 6, 2021 | Time not confirmed | -0.40 | -0.27 | +32.0% |
| Mar 1, 2021 | Time not confirmed | -0.44 | -0.53 | -21.6% |
| Nov 5, 2020 | Time not confirmed | -0.47 | -0.40 | +15.8% |
| Aug 6, 2020 | Time not confirmed | -0.42 | -0.50 | -19.0% |
| May 7, 2020 | Time not confirmed |
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through Oncology Innovation Platform and Commercial Platform segments. The company's Orascovery product candidates include Oral paclitaxel and encequidar for the treatment of metastatic breast cancer. It also offers Src Kinase product candidates comprising…
| -0.16 |
| -0.24 |
| -50.0% |
| Feb 27, 2020 | Time not confirmed | -0.31 | -0.28 | +9.7% |
| Nov 7, 2019 | Time not confirmed | -0.44 | -0.45 | -2.3% |
| Aug 7, 2019 | Time not confirmed | -0.41 | -0.44 | -7.3% |
| May 9, 2019 | Time not confirmed | -0.43 | -0.53 | -23.3% |
| Mar 11, 2019 | Time not confirmed | -0.20 | -0.41 | -105.0% |
| Nov 14, 2018 | Time not confirmed | -0.45 | -0.70 | -55.6% |
| Aug 14, 2018 | Time not confirmed | -0.48 | -0.58 | -20.8% |
| May 14, 2018 | Time not confirmed | -0.07 | -0.12 | -71.4% |
| Mar 26, 2018 | Time not confirmed | -0.16 | -0.49 | -206.3% |